Sort
11,323 grants matching “glioblastoma”
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
$469,538Xiaobo Zhou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · CA
The Role of HA Remodeling and Mesenchymal Transitions in Glioblastoma
$469,500Joseph Chen · University Of Louisville · R15 · FY2024 · CA
Improved delivery of gene therapies to the central nervous system by focused ultrasound-mediated disruption of the blood-brain barrier
$469,441Nicholas E. Todd · Brigham And Women'S Hospital · R01 · FY2022 · NS
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$469,316Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2016 · CA
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$469,316Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2015 · CA
Dissecting the biology and consequence of circulating glioma cells
$468,899Jay Fitzgerald Dorsey · University Of Pennsylvania · R01 · FY2022 · CA
Dissecting the biology and consequence of circulating glioma cells
$468,899Jay Fitzgerald Dorsey · University Of Pennsylvania · R01 · FY2023 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$468,752Robert M Prins · University Of California Los Angeles · R01 · FY2024 · CA
Project 1: Ionic Modulation of Chromatin in Cancer
$468,494Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2019 · CA
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM
$468,329Sarah J. Nelson · University Of California, San Francisco · R01 · FY2010 · CA
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
$468,207Mikhail Y Golovko · University Of North Dakota · R01 · FY2022 · NS
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
$468,207Mikhail Y Golovko · University Of North Dakota · R01 · FY2021 · NS
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
$468,207Mikhail Y Golovko · University Of North Dakota · R01 · FY2025 · NS
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
$468,207Mikhail Y Golovko · University Of North Dakota · R01 · FY2023 · NS
AI-powered chemical proteomics for drug discovery targeting orphan proteins
$467,952Lei Xie · Hunter College · R01 · FY2023 · GM
Cellular Transduction with Replication-Competent Retrovirus Vectors
$467,899Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2008 · CA
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$467,825James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM
$467,509Tayyaba Hasan · Massachusetts General Hospital · R01 · FY2013 · CA
Biophysical Interrogation of Signals that Drive GBM Invasion
$467,311Adam J Engler · University Of California, San Diego · R01 · FY2022 · NS
Biophysical Interrogation of Signals that Drive GBM Invasion
$467,311Adam J Engler · University Of California, San Diego · R01 · FY2023 · NS
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer
$467,151Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Master Regulatory MicroRNAs in Glioblastoma
$466,876Roger Abounader · University Of Virginia · U01 · FY2017 · CA
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$466,689Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS
Imaging Signaling Changes in Cancer and Treatment
$466,648Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
miRNA Expression Profiling
$466,613David M Brown · Ambion Diagnostics, Inc. · R44 · FY2007 · CA